FROM ALLOGENIC TRANSPLANTATION TO PRECISION IMMUNE THERAPY by Jean-François Rossi, MD PhD

Get full text

Azoximer bromide and hydroxyapatite: promising immune adjuvants in cancer by Jean-François Rossi, Patrick Frayssinet, Maksim Matciyak, Nikolai Tupitsyn

Get full text

γδ T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody by Mounia Sabrina Braza, Bernard Klein, Geneviève Fiol, Jean-François Rossi

Get full text

Optimisation of anti-interleukin-6 therapy: Precision medicine through mathematical modelling by Jean-François Rossi, Jean-François Rossi, Hao-Chun Chiang, Zhao-Yang Lu, Kalle Levon, Frits van Rhee, Karan Kanhai, David C. Fajgenbaum, David C. Fajgenbaum, Bernard Klein

Get full text

Identification of Anti-tumor Cells Carrying Natural Killer (NK) Cell Antigens in Patients With Hematological Cancers by Ewelina Krzywinska, Nerea Allende-Vega, Amelie Cornillon, Dang-Nghiem Vo, Laure Cayrefourcq, Catherine Panabieres, Carlos Vilches, Julie Déchanet-Merville, Yosr Hicheri, Jean-François Rossi, Guillaume Cartron, Martin Villalba

Get full text

REAL-LIFE STUDY OF BIO-CLINICAL FOLLOW-UP AFTER BNT162b2 mRNA COVID-19 (BNTCV) VACCINATION IN 235 PATIENTS (PTS) INCLUDING 225 WITH HEMATOLOGICAL MALIGNANCIES (HM). by Jean-François Rossi, Emmanuel Bonnet, Marion Velensek, Emma Wisniewski, Sophie Heraud, Rania Boustany, Céleste David, Jérôme Dinet, Roland Sicard, Jean-Pierre Daures, Marion Bonifacy, Lysiane Mousset, Christel Castelli, Emmanuel Goffart

Get full text

Clinical and Serological Follow-Up of 216 Patients with Hematological Malignancies after Vaccination with Pfizer-BioNT162b2 mRNA COVID-19 in a Real-World Study by Jean-François Rossi, Emmanuel Bonnet, Christel Castelli, Marion Velensek, Emma Wisniewski, Sophie Heraud, Rania Boustany, Céleste David, Jérôme Dinet, Roland Sicard, Jean-Pierre Daures, Marion Bonifacy, Lysiane Mousset, Emmanuel Goffart

Get full text

CD45 Isoform Profile Identifies Natural Killer (NK) Subsets with Differential Activity. by Ewelina Krzywinska, Amelie Cornillon, Nerea Allende-Vega, Dang-Nghiem Vo, Celine Rene, Zhao-Yang Lu, Christine Pasero, Daniel Olive, Nathalie Fegueux, Patrick Ceballos, Yosr Hicheri, Michal Sobecki, Jean-François Rossi, Guillaume Cartron, Martin Villalba

Get full text

Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma by Dirk Hose, Thierry Rème, Thomas Hielscher, Jérôme Moreaux, Tobias Messner, Anja Seckinger, Axel Benner, John D. Shaughnessy, Bart Barlogie, Yiming Zhou, Jens Hillengass, Uta Bertsch, Kai Neben, Thomas Möhler, Jean François Rossi, Anna Jauch, Bernard Klein, Hartmut Goldschmidt

Get full text

Evaluation of the (R)VAD+C regimen for the treatment of newly diagnosed mantle cell lymphoma. Combined results of two prospective phase II trials from the French GOELAMS group by Rémy Gressin, Sylvie Caulet-Maugendre, Eric Deconinck, Olivier Tournilhac, Emmanuel Gyan, Marie Pierre Moles, Abderrazak El Yamani, Jerome Cornillon, Jean François Rossi, Steven Le Gouill, Gérard Lepeu, Ghandi Damaj, Philippe Solal Celigny, Hervé Maisonneuve, Bernadette Corront, Jean Pierre Vilque, Philippe Casassus, Thierry Lamy, Marc Colonna, Philippe Colombat

Get full text